ENDO: Artificial pancreas promising in kids with T1D
from MedPage Today
An artificial pancreas system improved blood glucose control in children with type 1 diabetes without increasing hypoglycemia, according to a small study. In the randomized, cross-over trial, children (ages 5-8 years) with an artificial pancreas (AP) spent more time with his or her blood glucose levels in the normal range (70-180 mg/dL), compared with children with an insulin pump with continuous glucose monitoring (CGM) care at home.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063